In addition, the expression of ALDH3A2 in adenocarcinoma, ALDH7A1 in prostate cancer and glioma, and ALDH9A1 in breast cancer and thyroid cancer is also high. This evidence concerns the gene ALDH7A1 and prostate carcinoma.